Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea

Study limitation reported by the research below: “The FDA approval date for tirzepatide in OSA is stated as December 2024; brand name (Zepbound) for OSA indication inferred from context — confirm current label.”